Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
From Genome Web

FDA Approves Cepheid's Meningitis PCR-Based Dx Test; Shares Spike 7 Percent

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared a Cepheid test designed to help physicians detect viral meningitis within two-and-a-half hours, the FDA said today.

News of the clearance caused shares in Cepheid to trade up 7 percent today at $9.22 in the mid-afternoon.

Zz - Only have this in the contest, not reality.
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.